Sangamo Therapeutics (SGMO) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q2 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $21.4 million versus the consensus estimate of $21.43 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- CoStar Group acquires Zonda for $800M, adding new home data
- ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
